Companies / Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

Nasdaq: MDGLCIK 1157601WEST CONSHOHOCKEN, PA

Financials · FY2025

Revenue$958.40M
Net income$-288.28M
Total debt$340.79M
Cash$292.73M
Diluted EPS$-12.85
Shares outstanding23.1M

Ownership

23.1M shares outstanding · as of Jul 27, 2026
12.2%Insiders
Ownership
Insiders12.24%2,828,759
10%+ / strategic7.39%1,707,522
Institutions84.75%19,581,888
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 18

View all →
Insider% of sharesShares
8.44%1,948,876
Taub RebeccaDirector
1.96%452,667
0.81%187,164
Sibold William JohnCEOPresident and CEO · Director
0.70%161,829
0.10%22,469
Huntsman CaroleChief Commercial Officer
0.05%12,692
Dier MardiEVP and CFO
0.05%12,490
Kelley Shannon TGeneral Counsel
0.05%12,138
Soergel DavidChief Medical Officer
0.04%10,033
Daly James MDirector
0.01%3,081

Institutional holders 398

View all →
HolderValue% of shares
RTW Investments, LP$1.16B8.63%
Baker Bros. Advisors LP$1.12B9.27%
Vanguard Group Inc$1.05B7.83%
Avoro Capital Advisors LLC$1.05B7.82%
Janus Henderson Group PLC$1.05B8.74%
PAULSON & CO. INC.$728.77M6.03%
BlackRock, Inc.$644.75M5.20%
State Street Corporation$283.00M2.28%
Wellington Management Group LLP$268.69M2.00%
Fmr LLC$255.88M1.90%

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 9, 2026Friedman Paul a
Director
SellCommon Stock$1.28M-2K
-1.24%
194,222
0.84% of shares
medium
Jan 9, 2026Friedman Paul a
Director
SellCommon Stock$1.27M-2K
-1.20%
202,553
0.88% of shares
medium
Jan 20, 2026Taub Rebecca
Director
SellCommon Stock$1.10M-2K
-0.49%
453,351
1.96% of shares
medium
Jan 9, 2026Taub Rebecca
Director
SellCommon Stock$1.06M-2K
-0.44%
466,999
2.02% of shares
medium
Jan 9, 2026Friedman Paul a
Director
SellCommon Stock$1.03M-2K
-0.96%
205,769
0.89% of shares
medium
Jan 9, 2026Friedman Paul a
Director
SellCommon Stock$822.1K-2K
-0.81%
191,596
0.83% of shares
medium
Jan 9, 2026Taub Rebecca
Director
SellCommon Stock$814.0K-2K
-0.33%
469,564
2.03% of shares
medium
Jan 9, 2026Taub Rebecca
Director
SellCommon Stock$781.9K-1K
-0.32%
460,906
1.99% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
PAULSON & CO. INC.Passive13G/A1,707,522
Janus Henderson Group PLCPassive13G/A
PAULSON & CO. INC.Passive13G/A1,392,188
Janus Henderson Group PLCPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
MDGL558868105